Leading Edge Pharms, a CBD biotechnology company, yesterday announced the creation of LENCURA Direct, whose task will be distributing the company’s products by the end of 2019.
LENCURA Direct officially commenced operations in 2019 May, and forecasts over 600 active independent sales representatives before the fourth Quarter of 2019 ends. Representatives have already started selling the company’s product line of CANNAVERA™ topicals to small business and individual consumers.
Sina Downs, the Executive vice president and founder of LENCURA Direct, announced that the company has already established a core team of highly motivated professionals to kick off sales. LENCURA Direct has amazing and affordable natural products for safe pain, inflammation, and skin conditions treatment.
During the announcement, Diane Brown, the company’s executive vice president, and co-founder mentioned that LENCURA Direct has its own laboratory for research and a line of exciting CBD products in categories like skin care, pain relief, oral health, cosmeceuticals, pet care, wines, and teas. Diane insisted that LENCURA Direct is an excellent opportunity for persons looking to create supplemental income or build a career.
Flo McRae, CMA, also an executive vice president and the company’s co-founder, said that all co-founders had worked closely with the senior management of the company to come up with a unique model that gets rid of barriers for sales representatives looking to get into the cannabis market. The company looks to continue offering education, training salespersons and providing real-time support. The model is crafted to enable sales representatives to attain early success through assisting small businesses to enhance revenue and profitability.
Vice president and co-founder Diane Browning said that she was convinced that LENCURA Direct has the finest products that have been backed by proven research. Looking forward in great anticipation, Diane echoed that the sales program gives small businesses an easy path to compete and succeed in the exciting CBD field.
The President and CEO of Leading Edge Pharms, David Chadwick, said that with the leadership offered by the core sales management team, LENCURA Direct could swiftly start providing pain relief products to customers who need them, more so those who want opioid alternatives for pain management therapy.
Affiliate member organizations and sales representatives interested at joining the team at LENCURA Direct may inquire at lencuradirect.com
About Leading Edge
A true concept of the cannabis industry’s commercialization solution, Leading Edge combines clinical research and co-market capabilities with modern science manufacturing, data, and business technologies to advance product delivery. Leading Edge Pharms has been supported by regulatory and legislative advocacy, which in turn minimizes risk and expedites real cannabinoid healthcare innovations delivery to worldwide consumers.